Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$6.53 - $10.72 $979,500 - $1.61 Million
-150,000 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$6.16 - $9.6 $924,000 - $1.44 Million
150,000 New
150,000 $1.03 Million
Q2 2018

Aug 03, 2018

SELL
$16.77 - $24.71 $1.05 Million - $1.54 Million
-62,500 Closed
0 $0
Q4 2017

Jan 30, 2018

BUY
$11.23 - $19.1 $701,875 - $1.19 Million
62,500
62,500 $1.18 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.6B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.